SYMBIOFI is committed to the highest standards of scientific excellence

Developed by French state-supported biomedical research teams, our measurement engine is based on two patented, research-validated devices :

• Patent 1 : Method and device for filtering a series of cardiac rhythm signals (RR) derived from a cardiac signal, and more particularly an ECG signal.
  The device is used to guarantee optimal accuracy and to eliminate artefacts when analyzing heart rate variability.

• Patent 2 : Method and device for evaluating pain and stress in a living being.
  The device is used to analyze heart rate variability and to use resulting data to calculate the cardiac coherence parameter.